SR, L., AR, J., Y, J., MM, T., P, G., O, B., . . . LB, V. (2025). Pharmacotherapy for Alcohol Use Disorder Is Underutilized Among Commercially Insured Adults With Alcohol-Associated Liver Disease. Gastro hep advances, 4(10), 100799. https://doi.org/10.1016/j.gastha.2025.100799
Chicago Style (17th ed.) CitationSR, Lieber, et al. "Pharmacotherapy for Alcohol Use Disorder Is Underutilized Among Commercially Insured Adults With Alcohol-Associated Liver Disease." Gastro Hep Advances 4, no. 10 (2025): 100799. https://doi.org/10.1016/j.gastha.2025.100799.
MLA (9th ed.) CitationSR, Lieber, et al. "Pharmacotherapy for Alcohol Use Disorder Is Underutilized Among Commercially Insured Adults With Alcohol-Associated Liver Disease." Gastro Hep Advances, vol. 4, no. 10, 2025, p. 100799, https://doi.org/10.1016/j.gastha.2025.100799.